Cary-based Altavant Sciences dedicated to treatments for rare respiratory diseases

Altavant is developing rodatristat ethyl to treat pulmonary arterial hypertension (PAH) and ALTA-2530 for bronchiolitis obliterans syndrome (BOS).

Read More